(Q45333038)

13 December 2017

title

Polymorphisms of glutathione S-transferase μ and θ, MDR1 and VEGF genes as risk factors of bladder cancer: a case-control study (English)

1 reference

13 December 2017

7

1 reference

13 December 2017

3

Octavio P Luzardo

1 reference

13 December 2017

6

Manuel Zumbado

1 reference

13 December 2017

5

Luis D Boada

1 reference

13 December 2017

11

Pilar F Valerón

1 reference

Luis Alberto Henríquez-Hernández

13 December 2017

1

object named as

Luis Alberto Henríquez-Hernández

1 reference

13 December 2017

Eva Elisa Alvarez-León

4

object named as

Eva Elisa Alvarez-León

1 reference

13 December 2017

Patricio Navarro

2

1 reference

13 December 2017

Javier R Suárez

8

1 reference

13 December 2017

Nicolás Chesa

9

1 reference

13 December 2017

Maira Almeida

10

1 reference

13 December 2017

publication date

2 February 2011

1 reference

13 December 2017

1 reference

13 December 2017

volume

30

1 reference

13 December 2017

issue

5

1 reference

13 December 2017

page(s)

660-665

1 reference

Global cancer statistics, 2002

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

7 January 2021

Glutathione transferases

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Distribution of Ethylene Oxide in Human Blood and its Implications for Biomonitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Mammalian ABC transporters in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

The physiological function of drug-transporting P-glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

MDR1 C3435T polymorphism in patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Steroid and xenobiotic receptor (SXR), multidrug resistance gene (MDR1) and GSTs, SULTs and CYP polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Angiogenesis in bladder cancer--prognostic marker and target for future therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Association of VEGF genotype with mRNA level in colorectal adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Genetic variability in susceptibility and response to toxicants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Human glutathione S-transferases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

SHORT COMMUNICATION: Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Glutathione S-transferase M1, T1, and P1 gene polymorphism in laryngeal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Genetic polymorphism of glutathione S-transferases M1 and T1 in Egyptian patients with bilharzial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

GSTT1-null genotype is a protective factor against bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.028

10.1016/J.UROLONC.2010.08.028

7 January 2021

Identifiers

DOI

1 reference

13 December 2017

1 reference